Nephrotoxicity
19
4
5
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 19 trials
100.0%
+13.5% vs benchmark
21%
4 trials in Phase 3/4
38%
3 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (19)
Alpha-Lipoic Acid in Mitigating Cisplatin-Induced Nephrotoxicity
Renoprotective Role of Vitamin C and Coenzyme Q10 in Nephrotoxicity
Efficacy and Safety of N-Acetylcysteine Versus Alpha-Lipoic Acid in Colistin-Induced Nephrotoxicity
Effect of Huaier Granule on Nephrotoxicity Associated With Targeted Therapy for Advanced Hepatobiliary Malignancies.
L-Carnitine Protective Effect in Nephrotoxicity
Cisplatin Disposition and Kidney Injury
Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
Integrated Learning Support System Based on Immersive Simulated Training for Nursing Students
KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors (CCS)
Clinical Outcomes in Adult Patients Undergoing Laparoscopic Surgery Under Neuraxial Anesthesia
Assessment of Urinary Neutrophil Gelatinase-Associated Lipocalin to Predict AKI in the NICU
Vancomycin-Associated Nephrotoxicity
Assessment of Urinary NGAL to Predict AKI in Children Receiving Multiple Nephrotoxic Medications
Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
Effect of Intermittent Infusion Versus Continuous Infusion of Vancomycin on Kidney Failure in Critically Ill Patients
Switch From Calcineurin Inhibitor to Belatacept in Pancreas Transplant Recipients
0,9% NaCl Effect on Kidney Function and Glycocalyx in Patients Operated on for Primary Hiparthrosis
Aminoglycoside Plasma Level Measurement in Neonates With Infection
Evaluation of Intravenous N-acetylcysteine to Prevent Contrast Media Induced Nephrotoxicity in an Emergency Center